GetTopicDetailResponse(id=4d358106593, topicName=肌萎縮性側(cè)索硬化癥, introduction=肌萎縮性側(cè)索硬化癥, content=null, image=https://img.medsci.cn/2020122/1606873267461_4754896.jpg, comments=4, allHits=1997, url=https://h5.medsci.cn/topic?id=81065, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=95213, tagList=[TagDto(tagId=95213, tagName=肌萎縮性側(cè)索硬化癥)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2105935, encodeId=0a112105935f0, content=<a href='/topic/show?id=4d358106593' target=_blank style='color:#2F92EE;'>#肌萎縮性側(cè)索硬化癥#</a>好全面, objectTitle=肌萎縮性側(cè)索硬化癥, objectType=topic, longId=81065, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873267461_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=85, createdTime=2022-12-14, rootId=0, userName=ms5000001724145886, userId=6f675599545, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1180174, encodeId=794911801e401, content=<a href='/topic/show?id=4d358106593' target=_blank style='color:#2F92EE;'>#肌萎縮性側(cè)索硬化癥#</a>對肌肉的評價同樣十分重要, objectTitle=J Neurol Neurosur Ps：肌萎縮性側(cè)索硬化癥患者體重減輕的預(yù)后價值, objectType=article, longId=196898, objectId=981419689859, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202071/1593617632584_1739456.jpg, objectUrl=/article/show_article.do?id=981419689859, replyNumber=0, likeNumber=136, createdTime=2022-01-03, rootId=0, userName=病毒獵手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=981419689859, moduleTitle=J Neurol Neurosur Ps：肌萎縮性側(cè)索硬化癥患者體重減輕的預(yù)后價值, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=981419689859)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=882402, encodeId=82108824021c, content=<a href='/topic/show?id=4d358106593' target=_blank style='color:#2F92EE;'>#肌萎縮性側(cè)索硬化癥#</a>估計VitC，VitE，或其它抗氧化劑都有用！但是，事實(shí)上根本不解決根本問題。以前FDA批準(zhǔn)了<a href='/topic/show?id=07352693681' target=_blank style='color:#2F92EE;'>#依達(dá)拉奉#</a>治療這個疾病，其實(shí)作用是十分微弱的。苯丁酸鈉-?；嵌纪瑯尤绱? objectTitle=NEJM：苯丁酸鈉-?；嵌贾委熂∥s性側(cè)索硬化癥的療效分析, objectType=article, longId=200187, objectId=cd2520018ecd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202093/1599092574157_1739456.jpg, objectUrl=/article/show_article.do?id=cd2520018ecd, replyNumber=0, likeNumber=223, createdTime=2020-09-03, rootId=0, userName=1381abdab4m, userId=f0f41699279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd2520018ecd, moduleTitle=NEJM：苯丁酸鈉-牛磺二醇治療肌萎縮性側(cè)索硬化癥的療效分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cd2520018ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=882400, encodeId=8cb588240076, content=<a href='/topic/show?id=4d358106593' target=_blank style='color:#2F92EE;'>#肌萎縮性側(cè)索硬化癥#</a>, objectTitle=NEJM：苯丁酸鈉-?；嵌贾委熂∥s性側(cè)索硬化癥的療效分析, objectType=article, longId=200187, objectId=cd2520018ecd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202093/1599092574157_1739456.jpg, objectUrl=/article/show_article.do?id=cd2520018ecd, replyNumber=0, likeNumber=165, createdTime=2020-09-03, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd2520018ecd, moduleTitle=NEJM：苯丁酸鈉-牛磺二醇治療肌萎縮性側(cè)索硬化癥的療效分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cd2520018ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
